About us
Investor Relations
Products & Services
Genetic Toxicology
Support
Animal Welfare
Events
Career
Visit our main locations

Canada / Denmark / Hungary
 Events
Seminar: Practical Approaches to Dosing Route Challenges in Non-clinical Research
SOT 2009
Monday, 16 March 2009
 

SOT 2009, Baltimore, MD. Booth # 2815 (Mar15-19)
 

Subscribe to our Mailing list!
 Customer service
1-888-353-2240    
Document center   
Inquiry form   
Client center   

GenETIC toxicOLOGY

LAB Research has over 20 years of experience and expertise and the facilities to perform all standard genotoxicity and mutagenicity tests.  LAB Research has experience in testing pharmaceuticals, biopharmaceuticals, chemicals, agrochemicals as well as test articles such as medical devices and mixtures. We can make the appropriate recommendations on how to proceed on a case-by-case basis and how to test even the most unusual products.

Our tests comply with the latest versions of the guidelines formulated by ICH and OECD and performed in accordance with the current OECD Good Laboratory Practice guidelines to ensure their acceptability world wide.

Study Types
Genotoxicity
 Bacterial reverse mutation test / Bacterial gene mutation test (the Ames test) – OECD 471
 Mammalian chromosome aberration test in-vitro / Mammalian cytogenic test
  (using human lymphocytes) – OECD 473
 Mammalian cell gene mutation test in-vitro (using mouse lymphoma L5178Y
  cells) – OECD 476
 Mammalian erythrocyte micronucleus test in-vivo – OECD 474

Cytotoxicity
The tests in-vitro that LAB Research offers are very varied, and many have been developed to solve particular problems. Examples of tests offered routinely include the following:

 Elution and/or Direct contact Cytoxicity test  (Medical Devices + other classes)
 Haemolysis and coagulation (testing of haemocompatibility of Medical Devices)

Support Services
 We offer screening versions of the genotoxicity tests, which are useful during the
  early development of new products.

Staff
 Our staff actively participates in the revision process of many national and international 
  guidelines to ensure that all tests comply fully with the latest requirements.
....................................................................................................................................................................

 Stock quotes

 News  LAB Research News archives
LAB Research Announces its 2008 Third Quarter Financial Results
 

LAB Research to Hold Third Quarter 2008 Financial Results
 

 Investor relations
Dominic Sicotte
1.866.633.9551, ext. 101
dsicotte@echoesfinancial.com
     
Français | Home | About | Investor Relations | Careers | Corporate Profile | Products | Animal Welfare | Events | Customers Services
Copyright © 2006 LAB Research Inc. All Rights Reserved | Data Privacy Policy